Your browser doesn't support javascript.
loading
Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis.
Khan, S A; Kanis, J A; Vasikaran, S; Kline, W F; Matuszewski, B K; McCloskey, E V; Beneton, M N; Gertz, B J; Sciberras, D G; Holland, S D; Orgee, J; Coombes, G M; Rogers, S R; Porras, A G.
Affiliation
  • Khan SA; Department of Human Metabolism and Clinical Biochemistry, University of Sheffield Medical School, United Kingdom.
J Bone Miner Res ; 12(10): 1700-7, 1997 Oct.
Article in En | MEDLINE | ID: mdl-9333131
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Alendronate Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 1997 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Alendronate Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 1997 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos